Dynamic scientist and leader with extensive experience in pharmaceutical research, specializing in AI-enabled automated workflows for protein expression. Proven track record in managing cross-functional drug discovery projects, optimizing high-throughput systems, and leading diverse teams to achieve impactful results in early and late-stage development.
Overview
19
19
years of professional experience
Work History
Senior Scientific Manager and Group Leader
Genentech
South San Francisco
12.2020 - Current
Managed team of 6 direct reports and 4 extended reports at Genentech, driving innovation in AI-enabled automated workflows for protein expression and optimization across bacteria, insect cells, and mammalian systems.
Led biology project for small molecule drug discovery, collaborating cross-functionally to advance portfolio-based drug discovery and preclinical research; developed high-throughput in vitro biochemical assays and in vivo cell-based assays for validation of oncogenic targets and mutations in early stage drug discovery, and conducted large-scale functional genomics screens for biomarker discovery.
Leveraged 20 years of research experience in high-throughput protein expression, purification, and optimization to develop protein reagents for small and large molecule structure-based drug discovery; authored first author publications on key targets including kinases, ubiquitin ligases, GPCRs, and transcription factors.
Collaborated with proteomics and genomics group on various projects to enhance research outcomes.
Extensive business experience in working with CROs for managing large scale projects, multiple vendors for capital purchases and automation development.
Collaborated with proteomics and genomics groups on multiple projects.
Led scientific initiatives at Genentech, leveraging 10 years of experience in pharmaceutical industry; managed team of 6 direct reports and 4 extended reports to develop and optimize AI-enabled automated workflows for protein expression and optimization in bacteria, insect cells, and mammalian systems.
Conducted experiments to investigate drug efficacy and safety.
Collaborated with cross-functional teams to support clinical trial activities.
Analyzed data sets using statistical software to derive insights.
HHMI Research Associate/HFSP Post-doctoral fellow
University of California, Berkeley
Berkeley
07.2007 - 11.2013
Cell biologist and protein biochemist with more than 10 years of research experience and strong publication record in areas of membrane protein trafficking, vesicular protein trafficking particularly for large molecules like collagen; mammalian cell biology using engineered stable cell lines (retroviral and lentiviral), primary cells and stem cells, high-throughput in vitro biochemical reconstitution assays and protein-protein interactions.
Managed graduates and undergraduates on rotation projects; trained visiting fellow scientists in in vitro reconstitution assays with purified proteins to enhance their laboratory skills.
Molecular and Cell Biology, University of California, Berkeley.
Title: Senior Scientific Manager and Group Leader at Genentech
Awards
2017, Key Research Award at Genentech
2008, Human Frontier Science Program Organization (HFSPO) Long term post-doctoral fellowship award
2010, Indian National Science Academy Young Scientist Award
2000, Gold Medal from Delhi University, India
2003, Senior Research Fellowship from Council of Scientific and Industrial Research (CSIR), India
Publications
End to End Semi-automated Mid-scale Protein Screening Platform for drug discovery research, Inna Zilberleyb, Kanika Bajaj (Corresponding author), Current Protocols in Protein Science, 2023
Targeting ubiquitination dependent TEAD degradation in cancer, Kanika Bajaj Pahuja, Trang Pham, Anwesha Dey et al, elife, 2024
Actionable activating oncogenic ERBB2/HER2 transmembrane and juxtamembrane domain mutations, Kanika Bajaj Pahuja, Nguyen T, Jaiswal B, Seshagiri, S et al., Cancer Cell, 2018
Massively parallel single-cell B-cell receptor sequencing enables rapid discovery of diverse antigen-reactive antibodies, Communications Biology, 2019
Comprehensive genomic analysis identifies pathogenic variants in maturity-onset diabetes of the young (MODY) patients in South India, Viswanathan Mohan, Venkatesan Radha, Thong T. Nguyen, Eric W. Stawiski, Kanika Bajaj Pahuja et al, BMC Med Genet, 2018
Cell-free Generation of COPII-coated Procollagen I Carriers, Yuan Lin, Baba Satoshi, Bajaj Kanika, Schekman Randy, Bio-protocol, 2017
Phosphoregulatory protein 14-3-3 facilitates SAC1 transport from the endoplasmic reticulum., Pahuja Bajaj Kanika, Wang J, Blagoveshchenskaya A, Lim L, Madhusudhan MS, Mayinger P, Schekman R, Proc Natl Acad Sci U S A, 2015
Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes, Durinck S, Stawiski EW, Pavía-Jiménez A, Modrusan Z, Kapur P, Jaiswal BS, Zhang N, Toffessi-Tcheuyap V, Nguyen TT, Pahuja Bajaj Kanika et al., Nat Genet, 2015
Ubiquitin-dependent regulation of COPII coat size and function., Jin L
Pahuja Bajaj Kanika
Wickliffe KE, Gorur A, Baumgärtel C, Schekman R, Rape M., Nature, 2012
COPII and the regulation of protein sorting in mammals., Zanetti G, Pahuja Bajaj Kanika, Studer S, Shim S, Schekman R., Nat Cell Biol, 2011
SEC24A Deficiency Lowers Plasma Cholesterol through Reduced PCSK9 Secretion, Xiao-Wei Chen, He Wang, Kanika Bajaj, et al., e Life, 2013
The Sec233-Sec31 interface plays a critical role for export of procollagen from the endoplasmic reticulum., Kim SD, Pahuja Bajaj Kanika, Ravazzola M, Yoon J, Boyadjiev SA, Hammamoto S, Schekman R, Orci L, Kim J., J Biol Chem, 2012
Protein model discrimination using mutational sensitivity derived from deep sequencing., Adkar BV, Tripathi A, Sahoo A, Bajaj Kanika, Goswami D, Chakrabarti P, Swarnkar MK, Gokhale RS, Varadarajan R., Structure, 2012
Structural correlates of the temperature-sensitive phenotype derived from saturation mutagenesis of CcdB., Bajaj Kanika, Dewan PC, Chakrabarti P, Goswami D, Barua B, Baliga C, Varadarajan R., Biochemistry, 2008
Stereochemical criteria for prediction of the effects of Proline mutations on protein stability., Bajaj Kanika, Madhusudhan M, Adkar BV, Chakrabarti P, Ramakrishnan C, Sali A, Varadarajan R., Plos Computational Biology, 2007
Mutagenesis-based definitions and probes of residue burial in proteins., Bajaj Kanika, Chakrabarti P, Varadarajan R., Proc Natl Acad Sci U S A, 2005
Unfolding studies on soyabean agglutinin and concanavalin a tetramers: comparative account., Sinha S, Mitra N, Kumar G, Bajaj Kanika, Surolia A., Biophys J, 2005
Accurate detection of protein:ligand binding sites using molecular dynamics simulations., Bhinge A, Chakrabarti P, Uthanumallian K, Bajaj Kanika, Chakraborty K, Varadarajan R., Structure, 2004
Thermodynamic characterization of monomeric and dimeric forms of CcdB (controller of cell division or death B protein)., Bajaj Kanika, Chakshusmathi G, Bachhawat-Sikder K, Surolia A, Varadarajan R., Biochem J, 2004
Refolding and simultaneous purification by three-phase partitioning of recombinant proteins from inclusion bodies., Raghava S, Barua B, Singh PK, Das M, Madan L, Bhattacharyya S, Bajaj Kanika, Gopal B, Varadarajan R, Gupta MN., Protein Sci, 2008
Work Authorization Status
US citizen
Activities
Active reviewer for peer-reviewed international journals – e.g. Protein Science, Cell Stress & Chaperones, HFSP journal
American Society for Cancer Biology member and presented poster at AACR 2019
Presented as a speaker in Pep Talk and PEGS conferences
Team Leader, Senior Group Leader Engineering at New United Motors Manufacturing Inc.Team Leader, Senior Group Leader Engineering at New United Motors Manufacturing Inc.
Senior Manager, Scientific Buyer, Lab Equipment and Maintenance US at sanofiSenior Manager, Scientific Buyer, Lab Equipment and Maintenance US at sanofi